obesity medicine | Potere Health MD

Physician-guided weight loss consultation discussing GLP-1 medications like semaglutide and tirzepatide, with focus on safety, nutrition, and medical supervision.

Who Shouldn’t Take GLP-1 or GLP-1/GIP Weight Loss Medications? Semaglutide (Ozempic®, Wegovy®) and Tirzepatide (Mounjaro®, Zepbound®) Safety Explained

A physician-written guide explaining who should avoid or use caution with GLP-1 and GLP-1/GIP weight-loss medications like semaglutide and tirzepatide.

Joshua Silva, MD

Dec 29, 20257 min read

Zepbound tirzepatide FDA-approved treatment for obstructive sleep apnea in adults with obesity — SURMOUNT-OSA trial results.

Tirzepatide & Sleep Apnea

Zepbound (tirzepatide) is the first FDA-approved medication for obstructive sleep apnea in adults with obesity. Learn how it works and who may benefit.

Joshua Silva, MD

Oct 10, 20253 min read

Wegovy cardiovascular risk reduction — Potere Health MD, St. George & Cedar City, Utah

Wegovy (Semaglutide) Cardiovascular Risk Reduction

Wegovy (semaglutide) is FDA-approved to reduce major heart risks in adults with obesity/overweight and cardiovascular disease. Learn what it means and who qualifies.

Joshua Silva, MD

Sep 26, 20253 min read